Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Extravascular Lung Water Index and Pulmonary Vascular Permeability Index Assessed by the Transpulmonary Thermodilution Method in Patients After Minimally Invasive Cardiac Surgery With Cardiopulmonary Bypass and One Lung Ventilation
The use of cardiopulmonary bypass (CPB) combined with one lung ventilation (OLV) allows to
perform minimally invasive cardiac surgery (MICS) through small incisions. MICS is described
to be associated with similar outcomes compared with conventional surgery. Although less
invasive, MICS has not been reported to favorably impact the incidence of respiratory
failure after surgery.
The combination CPB and OLV may induce acute respiratory distress syndrome (ARDS). After CPB
contact of blood components with the artificial surface of the bypass, lung ischemia
reperfusion injury (LIRI) and operative trauma may trigger a systemic inflammatory response
syndrome (SIRS). During OLV, ARDS can result from hyperoxia, hyperperfusion and ventilatory
distress in the ventilated lung as well as from LIRI and operative trauma of the collapsed
lung.
Extravascular lung water (EVLW) includes all fluids in the lung except for those in the
vascular compartment. An excess of EVLW may lead to respiratory insufficiency. This may be
due to an increased hydrostatic intravascular pressure, as it occurs in cardiogenic
pulmonary edema, and/or by an increase of lung endothelial and epithelial permeability, as
in ARDS. The extravascular lung water index (EVLWI) assessed by the transpulmonary
thermodilution technique may be a useful tool for accurate diagnosis of ARDS, and the
pulmonary vascular permeability index (PVPI) may help in the differentiation between
pulmonary edema due to an increase in the pulmonary capillary permeability versus an
increase in the pulmonary capillary hydrostatic pressure.
As both CPB and OLV may induce an excess of EVLW, the investigators hypothesize that
patients after MICS with intraoperative combination of CPB and OLV may have higher EVLWI and
PVPI than those who received either CPB or OLV alone.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | April 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - age between 18 and 75 years, - written informed consent to participate in the study - one of following surgeries: mitral valve surgery with CPB, resection of pulmonary metastases with OLV, or minimally invasive mitral valve surgery with CPB and OLV. Exclusion Criteria: - chronic respiratory insufficiency - history of pulmonary resection or pneumonectomy - pulmonary thromboembolism - lung injury - severe peripheral arterial disease - emergency surgery - pregnancy |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Germany | Departement of Anaesthesiology and Critical Care Medicine, University Medical Center | Freiburg | Baden-Wuerttemberg |
Lead Sponsor | Collaborator |
---|---|
University Hospital Freiburg |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Extravascular lung water index (EVLWI) measured by a Pulse Contour Cardiac Output (PiCCO©) system device | EVLWI (ml/Kg) will be assessed after the induction of general anesthesia but before the surgery starts. This observational point is defined as T0. The observational time points T1, T2, T3 and T4 are 30 minutes, 6 hours, 12 hours and 24 hours, respectively, after stop of OLV and/or CPB. In case of OLV, an observational time point (Ta) will be added 15 minutes after start of the OLV. In patients with CPB and OLV, an additional time point (Tb) is 15 minutes after stop of the CPB while still under OLV. | T0= baseline; Ta= 15 minutes after start of the OLV; Tb=15 minutes after stop of the CPB while still under OLV; 30 minutes (T1), 6 hours (T2), 12 hours (T3) and 24 hours (T4) after stop of OLV and/or CPB. | No |
Primary | Pulmonary vascular permeability index (PVPI) measured by a Pulse Contour Cardiac Output (PiCCO©) system device | PVPI will be assessed after the induction of general anesthesia but before the surgery starts. This observational point is defined as T0. The observational time points T1, T2, T3 and T4 are 30 minutes, 6 hours, 12 hours and 24 hours, respectively, after stop of OLV and/or CPB. In case of OLV, an observational time point (Ta) will be added 15 minutes after start of the OLV. In patients with CPB and OLV, an additional time point (Tb) is 15 minutes after stop of the CPB while still under OLV. | T0, T1, T2, T3, T4, Ta, Tb | No |
Secondary | Any respiratory problem that the patient had during the postoperative period in the intensive care unit | One month after the surgery, any respiratory problem, such as infiltrate, atelectasis, pleural fluid, pneumonia or ARDS, that the patient had during the postoperative recovery period in the intensive care unit (ICU) will be assessed based on the medical records. Chest radiograph will be reviewed to assess the presence of infiltrates, atelectasis, pleural fluid and pulmonary edema. The pneumonia diagnosis will be based on the presence of pulmonary infiltrates and laboratory results. The Berlin definition will be used to establish the diagnosis of ARDS. | one month after the surgery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |